BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11913951)

  • 1. The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function.
    Merchant M; Swart R; Katzman RB; Ikeda M; Ikeda A; Longnecker R; Dykstra ML; Pierce SK
    Int Rev Immunol; 2001; 20(6):805-35. PubMed ID: 11913951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.
    Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M
    Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.
    Swanson-Mungerson M; Bultema R; Longnecker R
    J Gen Virol; 2010 Sep; 91(Pt 9):2197-202. PubMed ID: 20484564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.
    Rechsteiner MP; Bernasconi M; Berger C; Nadal D
    Trends Microbiol; 2008 Nov; 16(11):520-7. PubMed ID: 18835714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.
    Vrazo AC; Chauchard M; Raab-Traub N; Longnecker R
    PLoS Pathog; 2012; 8(4):e1002662. PubMed ID: 22536156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.
    Portis T; Cooper L; Dennis P; Longnecker R
    Front Biosci; 2002 Feb; 7():d414-26. PubMed ID: 11815296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus: exploiting the immune system.
    Thorley-Lawson DA
    Nat Rev Immunol; 2001 Oct; 1(1):75-82. PubMed ID: 11905817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
    Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
    J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.
    Engels N; Merchant M; Pappu R; Chan AC; Longnecker R; Wienands J
    J Exp Med; 2001 Aug; 194(3):255-64. PubMed ID: 11489945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.
    Caldwell RG; Wilson JB; Anderson SJ; Longnecker R
    Immunity; 1998 Sep; 9(3):405-11. PubMed ID: 9768760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse model for acute Epstein-Barr virus infection.
    Wirtz T; Weber T; Kracker S; Sommermann T; Rajewsky K; Yasuda T
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13821-13826. PubMed ID: 27856754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.
    Anderson LJ; Longnecker R
    Blood; 2009 Jan; 113(1):108-16. PubMed ID: 18815281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
    Portis T; Longnecker R
    Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.
    Ikeda M; Ikeda A; Longnecker R
    J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
    Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
    J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
    Konishi K; Maruo S; Kato H; Takada K
    J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
    Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
    J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Epstein-Barr virus latency by latent membrane protein 2.
    Longnecker R; Miller CL
    Trends Microbiol; 1996 Jan; 4(1):38-42. PubMed ID: 8824794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
    Portis T; Longnecker R
    Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
    Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
    Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.